财经首页 | 新浪首页 | 新浪导航
查看完整行情页>>

|

货币单位:美元(USD)

Summit Healthcare Acquisition Corp. (smih)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
提示:交易结束
Ken Poon Ken Poon occupies the position of President, Director & Co-Chief Investment Officer at Summit Healthcare Acquisition Corp. and President, Co-Chief Investment Officer & Director at Summit Healthcare Acquisition Sponsor LLC (a subsidiary of Summit Healthcare Acquisition Corp.). Mr. Poon is also on the board of Endeavor Acquisition Corp. (Cayman Islands) and Partner at Xcap Partners Ltd. In the past Mr. Poon was Head-Capital Markets Origination at Citigroup First Investment Management Ltd. and Head-Asia Equity Capital Markets at Merrill Lynch (Asia Pacific) Ltd. Ken Poon received an undergraduate degree from the University of British Columbia and an MBA from Guanghua School of Management.
Ian Charles Stone Ian Charles Stone is a businessperson who has been the head of 5 different companies. Presently, Mr. Stone holds the position of General Manager of Saudi Integrated Telecom Co. and Chief Executive Officer at CSL Mobile Ltd. Mr. Stone is also Member of The Hong Kong Institute of Directors and on the board of 5 other companies. In the past he held the position of Chief Executive Officer for UK Broadband Ltd., Managing Director at Pacific Link Communications Ltd, Chief Executive Officer at SmarTone Mobile Communications Ltd., Chief Operations Officer for Pilipino Telephone Corp. and Managing Director at HKT Teleservices International Ltd.
Tao Bai Tao Bai is Member of Inter-Pacific Bar Association, Member of All China Lawyers Association, Member of Chinese Society of International Law, Vice President at Beijing Lawyers Association and Partner at JunHe Law Office and on the board of 5 other companies. In the past Tao Bai occupied the position of Partner at Commerce & Finance Law Offices. Ms. Bai received a doctorate from Peking University Law School and a graduate degree from Cornell Law School.
Thomas Folinsbee Thomas Folinsbee is on the board of Summit Healthcare Acquisition Corp. and Director-Business Development of Shanghai Alebund Pharmaceuticals Ltd. Mr. Folinsbee previously was Director-Corporate Development at 3SBio, Inc. Mr. Folinsbee received an undergraduate degree from McGill University.